| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/24/1996 | EP0722312A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 07/24/1996 | EP0665850A4 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions. |
| 07/24/1996 | CN1127471A Compositions for inhalation |
| 07/24/1996 | CN1127470A Once-a-day methoprolol oral dosage form |
| 07/24/1996 | CN1127469A Sustained release excipient |
| 07/24/1996 | CN1127141A Molded articles and method of producing the same |
| 07/24/1996 | CN1127140A Cosmetic and skin-usefull composition containing water from hot spring, mineral water and agent against acne and oldening |
| 07/24/1996 | CN1032348C Method for prepn. of stable immunogen composition for oral administration |
| 07/23/1996 | US5539129 Nonionic amphiphilic compounds derived from glycerol, a process for preparing them, and corresponding intermediate compounds |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5538989 Fenbendazole formulations |
| 07/23/1996 | US5538951 Dipeptides of glutamic acid and tryptophan for immunology |
| 07/23/1996 | US5538946 Hirudin derivatives with delayed action |
| 07/23/1996 | US5538892 Nucleic acids encoding a TGF-β type 1 receptor |
| 07/23/1996 | US5538738 Retard systems for the sustained release of medicinal and/or biological valuable materials from a depot carrier material |
| 07/23/1996 | US5538728 Hydrophilic polymer-silicate mineral complex material and use thereof |
| 07/23/1996 | US5538726 Increasing residence time in tumor, injecting protein agglomerates to block blood circulation to and from tumor region |
| 07/23/1996 | US5538721 Stabilization of aminosteroids for topical ophthalmic and other applications |
| 07/23/1996 | CA2054188C Inclusion complexes of n-ethoxycarbonyl-3-morpholino- sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing thesame |
| 07/23/1996 | CA1338467C Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
| 07/18/1996 | WO1996021470A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 07/18/1996 | WO1996021469A1 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| 07/18/1996 | WO1996021468A2 Chemically modified interferon |
| 07/18/1996 | WO1996021467A1 BIOTHERAPY OF CANCER BY TARGETING TP-3/p80 |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996021462A1 Pharmaceutical compositions comprising a superoxide dismutase |
| 07/18/1996 | WO1996021453A1 Enrofloxacine injection or infusion solutions |
| 07/18/1996 | WO1996021446A1 Pharmaceutical composition with anti-alcoholic and nootropic properties |
| 07/18/1996 | WO1996021439A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 07/18/1996 | WO1996021434A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 07/18/1996 | WO1996021429A1 Pharmaceutical excipient having improved compressibility |
| 07/18/1996 | WO1996021428A1 Solid medicament form with active agent distributed in polymer material |
| 07/18/1996 | WO1996021427A1 Liquid polymer delivery system |
| 07/18/1996 | DE19501053A1 Stabilisatorgemisch aus Chromanderivaten und inerten organischen Lösungsmitteln sowie dieses Stabilisatorgemisch enthaltende Mikrokapseln Stabilizer mixture containing from chroman and inert organic solvents, and this stabilizer mixture microcapsules |
| 07/18/1996 | DE19500784A1 Enrofloxacin-Injektions- oder Infusionslösungen Enrofloxacin injection or infusion solutions |
| 07/18/1996 | CA2735293A1 Nadh and nadph therapeutic agents for dermal administration |
| 07/18/1996 | CA2210341A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 07/18/1996 | CA2210132A1 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 07/18/1996 | CA2209767A1 Biotherapy of cancer by targeting tp-3/p80 |
| 07/18/1996 | CA2209557A1 Chemically modified interferon |
| 07/18/1996 | CA2209492A1 Compositions for the delivery of antigens |
| 07/18/1996 | CA2167254A1 Controlled release of steroids from sugar coatings |
| 07/18/1996 | CA2167104A1 Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/17/1996 | EP0721785A2 Delittered ranitidin preparation |
| 07/17/1996 | EP0721776A1 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 07/17/1996 | EP0721478A1 Pyrrolidone-group-containing polyesters and polyamides |
| 07/17/1996 | EP0721349A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 07/17/1996 | EP0721348A1 Monoglyceride/lactate ester permeation enhancer |
| 07/17/1996 | EP0721344A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 07/17/1996 | EP0721343A1 Pharmaceutical formulations of nerve growth factor |
| 07/17/1996 | EP0721340A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 07/17/1996 | EP0721337A1 Oral formulations of an antifungal |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/17/1996 | EP0721327A1 Aerosol composition for forming a preferably hydrated membrane, preferably hydrated membrane so obtained, and applications thereofparticularly as a dressing |
| 07/17/1996 | EP0721326A1 Contraceptive compositions |
| 07/17/1996 | EP0681470B1 Recombinant living subunit vaccine composition and process for its preparation |
| 07/17/1996 | EP0601053A4 Compositions and methods for the sublingual or buccal administration of therapeutic agents. |
| 07/17/1996 | CN1126948A Methods and compositions for aiding periodontal tissue regeneration |
| 07/17/1996 | CN1126946A New pharmaceutical formulation |
| 07/16/1996 | US5536743 Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| 07/16/1996 | US5536735 Pharmaceutical composition |
| 07/16/1996 | US5536729 Rapamycin formulations for oral administration |
| 07/16/1996 | US5536642 Cell-associated interleukin-2 receptor a expression |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/16/1996 | US5536623 Method of producing highly water-soluble cyclodextrin complex |
| 07/16/1996 | US5536508 Biodegradable polymer and polysaccharide gel and bioadhesive with drug |
| 07/16/1996 | US5536506 Use of piperine to increase the bioavailability of nutritional compounds |
| 07/16/1996 | US5536475 Apparatus for magnetic cell separation |
| 07/16/1996 | US5536444 Compressed-gas packages using polyoxyethylene glyceryl fatty-acid esters as suspension stabilizers and valve lubricants |
| 07/11/1996 | WO1996021043A1 Using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | WO1996021036A2 Nucleic acid condensing agents with reduced immunogenicity |
| 07/11/1996 | WO1996020730A1 A chitosan polymer having a specific degree of acetylation |
| 07/11/1996 | WO1996020713A1 Treatment of hyperandrogenic conditions |
| 07/11/1996 | WO1996020712A1 Clear non-alcoholic hydrocortisone solutions |
| 07/11/1996 | WO1996020699A1 Composition and methods for transdermal delivery of acid-labile drugs |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996020696A1 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| 07/11/1996 | WO1996020688A2 Triggered pore-forming agents |
| 07/11/1996 | CA2209523A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | CA2208687A1 Treatment of hyperandrogenic conditions |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2206998A1 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| 07/11/1996 | CA2203632A1 A chitosan polymer having a specific degree of acetylation |
| 07/10/1996 | EP0720853A1 Topical administrable zinc phtalocyanine compositions |
| 07/10/1996 | EP0720485A1 Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| 07/10/1996 | EP0720476A1 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/$g(b)-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE |
| 07/10/1996 | EP0720473A1 Budesonide pellets with a controlled release pattern and process for producing them |
| 07/10/1996 | EP0626855A4 Health and beauty aid compositions. |
| 07/10/1996 | CN1126441A Amplification of the vitamin B12 uptake system using polymers |
| 07/10/1996 | CN1126440A Stabilized pharmaceutical peptide compositions |
| 07/10/1996 | CN1126436A Vitamin B12 mediated oral delivery systems for GCSF and EPO |
| 07/09/1996 | US5534555 Tableting excipient |
| 07/09/1996 | US5534554 Antiinflammatory, viricide, effective against herpes, aids |
| 07/09/1996 | US5534551 Production of powder which can be compressed into a tablet |
| 07/09/1996 | US5534505 Ursodeoxycholic acid-containing medicament in a liquid adminstration form |
| 07/09/1996 | US5534502 Process for producing fat emulsion |
| 07/09/1996 | US5534499 Drugs for attaching to phospholipids, glycerides, ceramide or 1,2-diacyloxy propane-3-amine |
| 07/09/1996 | US5534496 Methods and compositions to enhance epithelial drug transport |
| 07/09/1996 | US5534488 Combining zinc with insulin and proteins |
| 07/09/1996 | US5534414 Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein |